1. Home
  2. VLRS vs PHAT Comparison

VLRS vs PHAT Comparison

Compare VLRS & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Controladora Vuela Compania de Aviacion S.A.B. de C.V.

VLRS

Controladora Vuela Compania de Aviacion S.A.B. de C.V.

HOLD

Current Price

$6.57

Market Cap

823.2M

ML Signal

HOLD

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

HOLD

Current Price

$12.04

Market Cap

894.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VLRS
PHAT
Founded
2005
2018
Country
Mexico
United States
Employees
6901
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
823.2M
894.0M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
VLRS
PHAT
Price
$6.57
$12.04
Analyst Decision
Buy
Strong Buy
Analyst Count
8
6
Target Price
$9.16
$19.83
AVG Volume (30 Days)
477.9K
1.4M
Earning Date
04-27-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
42.72
EPS
N/A
N/A
Revenue
N/A
$175,110,000.00
Revenue This Year
$13.96
$93.04
Revenue Next Year
$12.62
$58.91
P/E Ratio
N/A
N/A
Revenue Growth
N/A
216.93
52 Week Low
$4.17
$3.69
52 Week High
$10.80
$18.31

Technical Indicators

Market Signals
Indicator
VLRS
PHAT
Relative Strength Index (RSI) 33.74 48.15
Support Level $6.39 $10.38
Resistance Level $7.50 $12.52
Average True Range (ATR) 0.27 0.98
MACD -0.08 -0.01
Stochastic Oscillator 1.29 61.97

Price Performance

Historical Comparison
VLRS
PHAT

About VLRS Controladora Vuela Compania de Aviacion S.A.B. de C.V.

Controladora Vuela Compania de Aviacion SAB de CV is a low-cost airline flying to Mexico, the United States, Central, and South America. It uses promotional fares to stimulate demand, and the base fares are priced to compete with long-distance bus fares in Mexico. Revenues from the air transportation of passengers are recognized earlier when the service is provided or when the non-refundable ticket expires on the date of the scheduled travel. Non-passenger revenues include revenues generated from other non-passenger services and cargo services. The Company has two geographic areas identified as domestic (Mexico) and international (United States of America, Central America, and South America).

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: